Recombinant multi-species ASCL1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ASCL1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors. The protein activates transcription by binding to the E box (5'-CANNTG-3'). Dimerization with other BHLH proteins is required for efficient DNA binding. This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons. Mutations in this gene may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ASCL1,ASH-1,ASH1,Achaete-scute homolog 1,Ascl1,Class A basic helix-loop-helix protein 46 (bHLHa46),HASH1,MASH1,Mash1,bHLHa46,hASH1
Go
to ASCL1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1510-Ag-1/ GM-Tg-hg-SE1510-Ag-2 | Human ASCL1 protein | Human |
| GM-Tg-rg-SE1510-Ag-1/ GM-Tg-rg-SE1510-Ag-2 | Rat ASCL1 protein | Rat |
| GM-Tg-mg-SE1510-Ag-1/ GM-Tg-mg-SE1510-Ag-2 | Mouse ASCL1 protein | Mouse |
| GM-Tg-cynog-SE1510-Ag-1/ GM-Tg-cynog-SE1510-Ag-2 | Cynomolgus/Rhesus macaque ASCL1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1510-Ag-1/ GM-Tg-felg-SE1510-Ag-2 | Feline ASCL1 protein | Feline |
| GM-Tg-cang-SE1510-Ag-1/ GM-Tg-cang-SE1510-Ag-2 | Canine ASCL1 protein | Canine |
| GM-Tg-bovg-SE1510-Ag-1/ GM-Tg-bovg-SE1510-Ag-2 | Bovine ASCL1 protein | Bovine |
| GM-Tg-equg-SE1510-Ag-1/ GM-Tg-equg-SE1510-Ag-2 | Equine ASCL1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1510-Ag-1/ GM-Tg-hg-SE1510-Ag-2;
GM-Tg-rg-SE1510-Ag-1/ GM-Tg-rg-SE1510-Ag-2;
GM-Tg-mg-SE1510-Ag-1/ GM-Tg-mg-SE1510-Ag-2; GM-Tg-cynog-SE1510-Ag-1/ GM-Tg-cynog-SE1510-Ag-2; GM-Tg-felg-SE1510-Ag-1/ GM-Tg-felg-SE1510-Ag-2; GM-Tg-cang-SE1510-Ag-1/ GM-Tg-cang-SE1510-Ag-2; GM-Tg-bovg-SE1510-Ag-1/ GM-Tg-bovg-SE1510-Ag-2; GM-Tg-equg-SE1510-Ag-1/ GM-Tg-equg-SE1510-Ag-2 |
| Products Name | ASCL1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ASCL1 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ASCL1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.